Table 5.
Parameter | ER | 95% CI | p value | |
---|---|---|---|---|
Intercept | 3.9136 | 1.8552 | 5.972 | 0.0002 |
Sex | 0.4541 | –0.0833 | 0.9914 | 0.0977 |
Age | –0.0248 | –0.0481 | –0.0015 | 0.0367 |
TMZ adjuvant | –0.5258 | –1.0418 | –0.0098 | 0.0458 |
IMRT | 0.0646 | –0.393 | 0.5223 | 0.7819 |
Delay to radiotherapy | 0.0001 | –0.0123 | 0.0125 | 0.9867 |
Radiotherapy duration | 0.0005 | –0.0032 | 0.0043 | 0.7755 |
Glioblastoma | 1.0763 | 0.338 | 1.8145 | 0.0043 |
Complete resection | –0.4928 | –0.9741 | –0.0115 | 0.0448 |
Seizure | –0.1411 | –0.662 | 0.3798 | 0.5955 |
Vomit | –0.1857 | –0.9142 | 0.5427 | 0.6173 |
Headache | –0.0157 | –0.5005 | 0.4692 | 0.9495 |
Mental confusion | –0.1527 | –0.7585 | 0.453 | 0.6212 |
Motor alteration | 0.4241 | –0.0702 | 0.9184 | 0.0927 |
Visual alteration | 0.749 | –0.4955 | 1.9936 | 0.2382 |
Scale | 0.4981 | 0.3662 | 0.6775 | |
Weibull shape | 2.0075 | 1.476 | 2.7304 |
ER, estimated risk; CI, confidence interval; TMZ, temozolomide; IMRT, intensity-modulated radiotherapy.
Boldface type indicates parameters with established relation and statistical significance in relation to the time to death.